TMCnet News
Research and Markets: Trypanosomiasis - Pipeline Review, H2 2013 Research ReportDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/z239dh/trypanosomiasis) has announced the addition of the "Trypanosomiasis - Pipeline Review, H2 2013" report to their offering. 'Trypanosomiasis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Trypanosomiasis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Trypanosomiasis. Scope - A snapshot of the global therapeutic scenario for Trypanosomiasis. - A review of the Trypanosomiasis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. >
- Coverage of the Trypanosomiasis pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Key Topics Covered: Introduction Trypanosomiasis Overview Therapeutics Development Pipeline Products for Trypanosomiasis - Overview Pipeline Products for Trypanosomiasis - Comparative Analysis Trypanosomiasis - Therapeutics under Development by Companies Trypanosomiasis - Therapeutics under Investigation by Universities/Institutes Trypanosomiasis - Pipeline Products Glance Early Stage Products Trypanosomiasis - Products under Development by Companies Trypanosomiasis - Products under Investigation by Universities/Institutes Trypanosomiasis - Companies Involved in Therapeutics Development Trypanosomiasis - Therapeutics Assessment Assessment by Monotherapy Products Assessment by Target (News - Alert) Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Assessment by Therapeutic Class Drug Profiles Subunit Vaccine For Trypanosomiasis - Drug Profile Xenomycin - Drug Profile Cysteine Proteases Inhibitors - Drug Profile Drug For Parasitic Diseases - Drug Profile Nitrobenzyl Phosphoramide Mustards - Drug Profile Trypanosomiasis - Recent Pipeline Updates Companies Mentioned iBio, Inc. Panacela Labs, Inc. For more information visit http://www.researchandmarkets.com/research/z239dh/trypanosomiasis About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
|